Home » COUGAR LICENSES RIGHTS TO SEOCALCITOL FROM LEO
COUGAR LICENSES RIGHTS TO SEOCALCITOL FROM LEO
June 29, 2005
Cougar Biotechnology, a privately held biotechnology company, today announced that it has licensed the worldwide, exclusive rights to seocalcitol from Dutch firm LEO Pharma A/S. Seocalcitol (EB1089) is a synthetic analog of vitamin D that has been clinically tested in a number of different cancer indications. The results of in vivo and in vitro studies have shown that vitamin D and analogs of vitamin D have anticancer activity in a wide range of tumor types.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1001241XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct